Literature DB >> 25023084

Prevalence of sickle cell disease in a pediatric population suffering from severe infections: a Congolese experience.

Diane A Kondani1, Jean Lambert Gini-Ehungu, Joseph M Bodi, Pépé M Ekulu, Thomas S Kunuanunua, Michel N Aloni.   

Abstract

Neonatal screening for sickle cell anemia is not a common practice in the Democratic Republic of Congo (DRC). Children with sickle cell disease are known to have an increased risk of infections. We conducted a pilot study to determine the prevalence of sickle cell anemia during episodes of severe infection. A prospective study was conducted from July 2009 to July 2011. The study sites included four public hospitals at Kinshasa, DRC. The study population was selected from the source population using three-stage sampling. A total of 247 children with severe infection were consecutively recruited and screened for sickle cell disease. There were 124 boys (50.2%) and 123 girls (49.8%) with a sex-ratio of 1:1. More than two-thirds of patients (66.0%) were children between 1 and 24 months of age. Among these 247 children, 19 (7.7%) were homozygous sickle cell anemia patients (Hb SS). No patient had received Hemophilus influenzae, streptococcus pneumoniae and salmonella sp vaccines. Sepsis was the most common form of severe infection observed in 44.5% of patients. A total of 19 (7.7%) positive blood cultures were recorded. Most cases were reported in sickle cell patients (15.8%) compared to 6.1% in children who were negative for Hb S [β6(A3)Glu→Val; HBB: c.20A>T] (p > 0.05). Of 247 children with severe infection, approximately 8.0% carried unknown sickle cell anemia mutations. Based on the findings in this study, opportunistic testing for sickle cell anemia is possible and worthwhile in children who present with severe infection in DRC until neonatal screening is universal.

Entities:  

Keywords:  Children; Democratic Republic of Congo (DRC); Kinshasa; severe infection; sickle cell anemia

Mesh:

Substances:

Year:  2014        PMID: 25023084     DOI: 10.3109/03630269.2014.917658

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  5 in total

1.  Validity of simple clinical and biological parameters as screening tool for sickle cell anemia for referral to tertiary center in highly resource constraints.

Authors:  Bertin Tshimanga Kadima; Jean Lambert Gini-Ehungu; Fiston Ikwa Ndol Mbutiwi; John Tunda Bahati; Michel Ntetani Aloni
Journal:  J Clin Lab Anal       Date:  2017-01-17       Impact factor: 2.352

2.  The gut microbiome in sickle cell disease: Characterization and potential implications.

Authors:  Hassan Brim; James Taylor; Muneer Abbas; Kimberly Vilmenay; Mohammad Daremipouran; Sudhir Varma; Edward Lee; Betty Pace; Waogwende L Song-Naba; Kalpna Gupta; Sergei Nekhai; Patricia O'Neil; Hassan Ashktorab
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

3.  Acute Crises and Complications of Sickle Cell Anemia Among Patients Attending a Pediatric Tertiary Unit in Kinshasa, Democratic Republic Of Congo.

Authors:  Michel Ntetani Aloni; Bertin Tshimanga Kadima; Pépé Mfutu Ekulu; Aléine Nzazi Budiongo; René Makuala Ngiyulu; Jean Lambert Gini-Ehungu
Journal:  Hematol Rep       Date:  2017-06-01

4.  [Acceptability of neonatal screening of the sickle cell disease during the pandemic of COVID-19 in Kisangani, Democratic Republic of the Congo].

Authors:  Emmanuel Tebandite Kasai; Jean Pierre Alworong A Opara; Salomon Batina Agasa; Béatrice Gulbis; Naura Apio Uvoya; Jean Didier Bosenge Nguma; Philippe Kasongo Maloba; Philippe Hubert; Anne-Marie Etienne; Roland Marini Djang Eing A
Journal:  Pan Afr Med J       Date:  2020-12-02

5.  [Awareness and attitudes of 50 congolese families affected by sickle cell disease: a local survey].

Authors:  Benoît Mbiya Mukinayi; Didier Kalombo Kalenda; Stéphanie Mbelu; Béatrice Gulbis
Journal:  Pan Afr Med J       Date:  2018-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.